Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury

Background: Vancomycin is commonly used as a first line therapy for gram positive organisms such as methicillin resistant Staphylococcus aureus. Vancomycin-induced acute kidney injury (V-AKI) has been reported in up to 43% of patients, especially in those with higher targeted trough concentrations....

Descripción completa

Detalles Bibliográficos
Autores principales: Awdishu, Linda, Le, Amy, Amato, Jordan, Jani, Vidhyut, Bal, Soma, Mills, Robert H., Carrillo-Terrazas, Marvic, Gonzalez, David J., Tolwani, Ashita, Acharya, Anjali, Cerda, Jorge, Joy, Melanie S., Nicoletti, Paola, Macedo, Etienne, Vaingankar, Sucheta, Mehta, Ravindra, RamachandraRao, Satish P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999309/
https://www.ncbi.nlm.nih.gov/pubmed/33801801
http://dx.doi.org/10.3390/ijms22062784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999309/
https://www.ncbi.nlm.nih.gov/pubmed/33801801
http://dx.doi.org/10.3390/ijms22062784

Ejemplares similares